A comprehensive view of Capsules / Pills / Tablets. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Sustainability & Social Responsibility Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Cofepris issues favorable opinion for Pfizer's oral COVID-19 treatment, enabling potential nationwide distribution in Mexico; the Commission is expected to make a final ruling in the coming weeks
Published: April 24, 2024 by CE Noticias Financieras (Latin America)
KORSCH America receives an Exhibitor Award at INTERPHEX NYC for their recently launched X 5 Tablet Press; the press is designed for increased single-sided output and flexibility in high-volume environments
Published: April 24, 2024 by WhatTheyThink
The FDA approves ViiV Healthcare’s Dovato (dolutegravir/lamivudine) for adolescents aged 12 and above for the treatment of HIV-1 infection; Dovato offers a single-tablet, two-drug oral regimen for HIV therapy
Published: April 08, 2024 by GSK Group (GlaxoSmithKline)
Evonik highlights its EUDRAGIT brand of polymers as key ingredients in coating systems for pharmaceuticals; company introduces EUDRACAP, an option for enteric capsule production
Published: April 04, 2024 by Evonik Industries AG
Upsher-Smith Laboratories launches Methimazole tablets, USP, 5 mg and 10 mg., in the US with potential market value of US$36.8M; original reference is Pfizer's brand Tapazole
Published: April 01, 2024 by M2 Pharma

Ask us about our Sustainability & Social Responsibility market view

Trending Chart

Interactive chart with headline count